An open-label multicenter randomized Phase 3 study compa

Project: Research project

Description

An open-label multicenter randomized Phase 3 study comparing then combination of DOXIL/CAELYX and YONDELIS with DOXIL/CAELYX alone in subjects with advanced relapsed ovarian cancer - Protocol ET743-OVA-301
StatusFinished
Effective start/end date3/3/067/31/11

Funding

  • JOHNSON AND JOHNSON MED INC

Fingerprint

Ovarian Neoplasms